List View Detail View 301-325 of 384 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 12 13 14 ... 16 Next Product Clone Appl. Reg Cat# Size Brilliant Violet 510™ anti-human CD10 Antibody HI10a FC RUO 312219 25 tests ¥34,360 312220 100 tests ¥90,860 Brilliant Violet 510™ anti-human CD86 Antibody IT2.2 FC RUO 305431 25 tests ¥44,880 305432 100 tests ¥88,440 Brilliant Violet 510™ anti-mouse/human CD45R/B220 Antibody RA3-6B2 FC, IHC-F, SB RUO 103247 125 µL ¥36,300 103248 50 µg ¥51,730 Brilliant Violet 510™ anti-human CD61 Antibody VI-PL2 FC RUO 336433 25 tests ¥38,500 336434 100 tests ¥89,100 Brilliant Violet 510™ anti-human CD31 Antibody WM59 FC RUO 303158 100 tests ¥82,500 Brilliant Violet 510™ anti-human CD184 (CXCR4) Antibody 12G5 FC RUO 306535 25 tests ¥45,980 Brilliant Violet 510™ anti-human CD16 Antibody 3G8 FC RUO 302048 100 tests ¥66,930 Brilliant Violet 510™ anti-mouse H-2Kb Antibody AF6-88.5 FC RUO 116523 50 µg ¥53,900 Brilliant Violet 510™ anti-human CD62P (P-Selectin) Antibody AK4 FC RUO 304936 100 tests ¥88,440 Brilliant Violet 510™ anti-human CD134 (OX40) Antibody Ber-ACT35 (ACT35) FC RUO 350026 100 tests ¥93,280 Brilliant Violet 510™ anti-human/mouse/rat CD278 (ICOS) Antibody C398.4A FC RUO 313525 25 tests ¥43,560 Brilliant Violet 510™ anti-human CD196 (CCR6) Antibody G034E3 FC RUO 353423 25 tests ¥47,300 353424 100 tests ¥95,700 Brilliant Violet 510™ anti-mouse CD326 (Ep-CAM) Antibody G8.8 FC RUO 118231 50 µg ¥63,230 Brilliant Violet 510™ anti-human CD163 Antibody GHI/61 FC RUO 333627 25 tests ¥38,720 333628 100 tests ¥83,600 Brilliant Violet 510™ anti-mouse/rat/human CD27 Antibody LG.3A10 FC RUO 124229 50 µg ¥55,440 Brilliant Violet 510™ anti-mouse H-2Kd Antibody SF1-1.1 FC RUO 116625 50 µg ¥64,240 Brilliant Violet 510™ anti-mouse Siglec-G Antibody SH1 FC RUO 163323 50 µg ¥59,400 Brilliant Violet 510™ anti-human CD117 (c-kit) Antibody W18195C FC RUO 375313 25 tests ¥42,900 375314 100 tests ¥91,300 Results Per Page: 25 50 100 200 Previous 1 ... 12 13 14 ... 16 Next
Follow Us